Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.29
Delayed Data
As of May 25
 -0.02 / -0.87%
Today’s Change
1.90
Today|||52-Week Range
7.70
-58.80%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close2.31
Today’s open2.36
Day’s range2.21 - 2.36
Volume111,884
Average volume (3 months)325,416
Market cap$10.6M
Data as of 3:59pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)-3.26%
Earnings growth (next 5 years)--
Revenue growth (last year)-21.05%
P/E ratioNM
Price/Sales836.57
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
NDRAENDRA Life Sciences ...+0.04+1.90%
XTNTXtant Medical Holdin...+0.13+2.16%
GENEGenetic Technologies...-0.01-0.82%
SNGXSoligenix Inc0.000.00%
Data as of 8:00pm ET, 05/25/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$15.0K
Annual profit (last year)-$12.5M
Net profit margin-83,013.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Secretary &
Finance Director
Caitlin Kontulis
Corporate headquarters
Marlborough, Massachusetts

Forecasts